This website use cookies and similar technologies to improve the site and to provide customised content and advertising. By using this site, you agree to this use. To learn more, including how to change your cookie settings, please view our Cookie Policy
Pocketmags Digital Magazines
Pocketmags Digital Magazines
   You are currently viewing the Canada version of the site.
Would you like to switch to your local site?
Digital Subscriptions > > INSIDER KNOWLEDGE


Solomon Nevins brings his experience to bear on the alternatives market, discussing the biggest challenges, the greatest opportunities and how the team of fund experts at Architas are riding out the storms of today’s macroeconomic climate

What are the challenges with real assets right now?

The impact of rising yields on the real assets sector is something we have to watch. It’s difficult to know how the Brexit negotiations will pan out and what that will mean for sterling, inflation and interest rates.

However, the underlying projects have been performing well and are not affected by higher yields currently, so the challenge is more around risks from changes in investor sentiment and how that affects fund prices.

Where are the best new opportunities?

We are looking at the opportunities in healthcare royalties.

Owning royalty rights to a range of drugs would deliver returns as revenue from sales. It’s an interesting asset class on the basis that drug demand is very lowly correlated with traditional investments.

Purchase options below
Find the complete article and many more in this issue of -
If you own the issue, Login to read the full article now.